iTind: Clinical Trials

5 trials of iTind, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting, 1 terminated. 4 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Recruiting 1, Terminated 1, Unknown 1
Phase 31Unknown 1

Follow iTind: new trials by email Literature Review of iTind trials Research Report on iTind

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Outcomes of MIST for BPH: A Single-Institution Prospective Study
Rezum, iTind - Benign Prostatic Hyperplasia
Phase 3UnknownUniversity of Manitoba202024-03-012024-02-23
Post-Market Study to Assess iTind Safety in Comparison to UroLift
iTind, UroLift - Benign Prostatic Hyperplasia (BPH)
Not applicableRecruitingOlympus Corporation of the Americas2562022-09-262026-09-29
Study to Assess the Efficacy, Safety and Tolerability of (iTind)
iTind - BPH
Not applicableTerminatedMedi-Tate Ltd.52018-02-272020-07-22
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
iTind - BPH
Not applicableUnknownMedi-Tate Ltd.1492018-02-182023-10-23
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
iTIND, Sham Arm - Benign Prostate Hyperplasia
Not applicableCompletedMedi-Tate Ltd.1852015-07-012022-02-28

Conditions studied

Prostatic Hyperplasia (3)

Sponsors

Medi-Tate Ltd. (3)  ·  Olympus Corporation of the Americas (1)  ·  University of Manitoba (1)

Countries

Canada (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Bilal Chughtai, MD (1)  ·  Francesco Porpiglia, MD (1)  ·  Gordon Muir, MD (1)  ·  Neil Barber, MD (1)  ·  Sheldon Pike, MD (1)

Results publications

PMID 36070450